U.S. Basic Materials Stock News

H World Group (HTHT) just packed several catalysts into one update, combining its 2025 earnings release with fresh guidance, a sizeable dividend, ongoing buybacks, and a chief financial officer transition. See our latest analysis for H World Group. At a share price of US$50.53, H World Group has a 1-year total shareholder return of 41.17% and a 3-year total shareholder return of 13.76%. This suggests longer term holders have seen stronger momentum than more recent buyers, despite a softer 30...

Gold.com, Inc. has appointed Juan Sartori to its Board of Directors, while longtime director Beverley Lepine has retired after more than a decade of service. Sartori’s experience in large-scale investments across gold, land, agriculture, and other commodities could influence how Gold.com thinks about future capital allocation and partnerships. We’ll now examine how Sartori’s commodities-focused background might shape Gold.com’s existing investment narrative and longer-term business...

In recent days, monday.com has faced a wave of securities class action filings alleging misleading disclosures about its revenue expansion outlook, while also registering a shelf for roughly US$188.22 million of ESOP-related ordinary shares. At the same time, the company unveiled new infrastructure that allows external AI agents to sign up, authenticate, and operate directly inside its work management platform, expanding how humans and AI collaborate on monday.com. Next, we'll examine how...

For investors wondering whether ConocoPhillips at around US$126 a share still offers value or if the easy money has already been made, this article examines what the current price might be implying. The stock has recently shown strong momentum, with returns of 4.8% over 7 days, 15.8% over 30 days, 30.3% year to date and 27.4% over the past year. These moves come against a backdrop of ongoing attention on energy producers like ConocoPhillips. Market focus includes capital allocation...

If you are wondering whether Union Pacific at around US$234.18 is offering fair value or an opportunity, the recent share performance gives you a useful starting point. The stock has seen a 4.1% decline over the last 7 days and a 10.9% decline over the last 30 days, while still showing a 1.0% return year to date and a 2.1% return over the past year, alongside 34.7% and 21.3% returns over the last 3 and 5 years respectively. These moves come as investors keep an eye on Union Pacific as one of...

If you are trying to work out whether Federal Home Loan Mortgage at US$4.41 is still attractively priced or now carrying more risk, the recent share moves give you plenty to think about. The stock has seen a 16.9% decline over the last 7 days and a 36.4% decline over the last 30 days, yet it still sits on a 137.1% return over 5 years and a very large return over 3 years that is above 10x. These sharp short term moves and the strong multi year performance have kept valuation in focus for...

Earlier this quarter, filings showed that Fisher Asset Management increased its stake in HEICO Corporation by 13%, reinforcing the aerospace and defense supplier’s appeal among institutional investors. This growing interest from a long-term, research-driven fund underscores how HEICO’s role as a diversified aerospace and defense supplier is attracting focused institutional capital. Next, we’ll examine how Fisher Asset Management’s enlarged position could influence HEICO’s investment...

KE Holdings Inc. has already announced its Q4 and full-year 2025 results, reporting quarterly revenue of CNY 22,188.77 million and net income of CNY 87.85 million, alongside a new annual dividend of US$0.2260 per share payable on April 24, 2026. Along with a large-scale share repurchase program that has retired 41.14% of its shares since 2022 and inclusion in the Hang Seng China Enterprises Index, the company is emphasizing cost efficiency, AI-driven operations, and growing non-transaction...

In recent updates, Expand Energy outlined expectations for ongoing operational efficiencies in Fiscal 2026, including higher well productivity in the Haynesville formation and lower capital costs per foot across its natural gas and oil shale assets in Louisiana, Pennsylvania, West Virginia, and Ohio. This focus on productivity and cost discipline highlights how technology-driven improvements in core shale regions may increasingly shape the company’s operational profile and capital allocation...

FedEx (NYSE:FDX) is accelerating its Network 2.0 consolidation, including plans to close nine key shipping facilities. The company is moving toward a unified surface network that is intended to reshape its U.S. ground operations footprint. FedEx also plans a minority investment in InPost, a European out of home delivery specialist, signaling a push in parcel locker and pickup point services. For investors watching FedEx at a share price of $356.11, these moves highlight how the company is...

Large shareholder trims stake in Remitly Global (RELY) Naspers has sold 12 million Remitly Global (RELY) shares in the open market, cutting its indirect stake by about 47% and taking its holding below the SEC's 10% reporting threshold. The company has previously described Remitly as a non core asset. This sale fits within Naspers's broader divestiture program and puts fresh attention on Remitly's evolving ownership base and liquidity profile. See our latest analysis for Remitly...

In March 2026, Erasca, Inc. reported a full-year 2025 net loss of US$124.55 million, with basic loss per share from continuing operations of US$0.44, both improving versus the prior year. Earlier that month, Erasca exercised its option to expand its license with Joyo Pharmatech, securing exclusive global rights to the potential pan-RAS molecular glue ERAS-0015 and enabling a single worldwide development and commercialization plan. With Erasca now holding worldwide rights to ERAS-0015, we’ll...

In recent months, AST SpaceMobile has secured a US$30 million U.S. Space Development Agency contract, expanded commercial partnerships such as a Telus deal that includes an equity stake, advanced its BlueBird 6 and 7 satellite deployments, and reported its first year of revenue driven by multiple U.S. government contracts. These developments, alongside a US$1.20 billion contracted backlog, partnerships with more than 50 mobile network operators and increasing institutional ownership from...

CytomX Therapeutics recently reported full-year 2025 results showing sales of US$76.2 million and a net loss of US$17.37 million, and has just raised roughly US$250.00 million through a follow-on offering of common stock and pre-funded warrants at about US$5.30 per security. At the same time, the company released encouraging Phase 1 data for its EpCAM-targeted ADC Varseta-M in heavily pretreated metastatic colorectal cancer, with a high disease control rate and a safety profile that appears...

Elastic N.V. (NYSE:ESTC) is scheduled to participate in the HIMSS 2026 Global Health Conference & Exhibition. The event is one of the larger gatherings focused on healthcare IT and digital health solutions. Elastic's presence highlights its efforts to engage with healthcare providers, payers, and technology partners. For investors watching NYSE:ESTC, this appearance puts Elastic in front of a healthcare audience that depends heavily on search, observability, and data security tools...

Five Below (FIVE) has wrapped up FY 2026 with fourth quarter revenue of US$1.7b and basic EPS of US$4.32, supported by same store sales growth of 15.4%. Over the past few quarters, the company has seen revenue move from US$843.7m in Q3 2025 to US$1.0b in Q3 2026 and US$1.7b in Q4 2026, while quarterly basic EPS shifted from US$0.03 in Q3 2025 to US$0.66 in Q3 2026 and US$4.32 in the latest quarter, with trailing twelve month EPS at US$6.51. With trailing twelve month same store sales growth...

If you are wondering whether Ultragenyx Pharmaceutical's current share price reflects its true worth, the recent valuation checks offer some useful clues for your own research. The stock last closed at US$20.42, with returns of a 5.9% decline over 7 days, 1.2% over 30 days, a 13.5% decline year to date, and a 47.5% decline over the past year, which may change how you think about its risk and return profile. Ultragenyx has been in focus as investors reassess higher risk biotech names, and...

Titan America (NYSE:TTAM) has agreed to acquire Keystone Cement, expanding its presence and capacity in the Mid-Atlantic region. The company reports record revenue, EBITDA and operating cash flows for 2025, despite sector headwinds. These developments have not yet been widely discussed and may reshape Titan America's growth profile and operational footprint. For investors tracking NYSE:TTAM, the stock last closed at $14.71, with a 1 year return of 15.1% and a 12.0% decline year to date...

Callaway Golf stock in focus after name change Callaway Golf (CALY) is back in the spotlight after reverting to its historic name in January 2026, following a period as Topgolf Callaway Brands Corp. The move is drawing fresh attention to its core golf equipment and apparel business. See our latest analysis for Callaway Golf. The recent name change headlines arrive as momentum rebuilds, with a 16.9% year to date share price return and a 107.3% 1 year total shareholder return contrasting with...

Wondering if Colgate-Palmolive at around US$85.50 is offering fair value, or if you might be paying up for a quality brand name. The stock is up 10.1% year to date, even after a 2.8% slip over the last week and a 10.6% pullback over the past month. The 1-year return sits at a 3.0% decline and the 3- and 5-year returns are 27.8% and 23.6% respectively. These mixed returns often prompt investors to reassess what they are really paying for, especially when a consumer staple name like...

Why Protalix BioTherapeutics is Back on Investors’ Radar Protalix BioTherapeutics (PLX) has drawn fresh attention after the European Commission approved a new Elfabrio dosing regimen for certain Fabry disease patients, alongside updated 2026 revenue guidance that includes a US$25 million regulatory milestone. See our latest analysis for Protalix BioTherapeutics. The Elfabrio dosing news and 2026 guidance update arrive after a mixed share price pattern, with a 28.9% 90 day share price return...

Royal Caribbean Cruises (NYSE:RCL) has announced Royal Beach Club Lelepa, the first exclusive Royal Beach Club destination in the Southern Hemisphere. The company plans an expanded 2027 to 2028 cruise lineup across Australia, the South Pacific, New Zealand, and Asia. The program includes the return of key ships to Asia and Australia, with new itineraries aimed at attracting both new and repeat guests. Royal Caribbean Cruises, trading around $272.0, has seen a 3 year return of about 7x and a...

Recent commentary around Lam Research (LRCX) centers on its role in supplying equipment for AI focused data centers, with demand tied to DRAM, NAND, foundry spending, and process steps such as 3D DRAM and advanced packaging. See our latest analysis for Lam Research. At a share price of US$233.99, Lam Research has recently seen strong short term momentum, with a 4.13% 1 day share price return and 35.83% 90 day share price return. The 1 year total shareholder return of 203.94% and 5 year total...

Rare disease growth and Alimera deal draw fresh attention to ANI Pharmaceuticals ANI Pharmaceuticals (ANIP) is back on investor radar after strong growth in its rare disease business, led by Cortrophin Gel, and the completed acquisition of Alimera Sciences, which expanded the company’s ophthalmology product portfolio. See our latest analysis for ANI Pharmaceuticals. The recent attention around Cortrophin Gel and the Alimera deal comes as ANI’s share price, now at US$74.82, shows softer short...